Look for:

Our offer for

GRIFOLS SA


ISIN:
ES0171996087
WKN:
-
2024/09/18 17:35:08
Price
10.06 EUR
Difference -2.00% (-0.21)

General attributes

ISINES0171996087
SymbolGRF
ExchangeBME Continuous Market
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)6,378 EUR
BenchmarkIBEX 35

Market data

Bid (Bid size)-
Ask (Ask size)-
Open10.225 EUR
High10.235 EUR
Low10.005 EUR
Close (prev. day)10.265 EUR
VWAP10.084701 EUR
Volume (pcs)1,079,004
Trading volume10,881,432.52
Number of trades1,943
Last size-

Futures and Options

Related Futures33
Related Options-

PDF Downloads

Company report: GRIFOLS SAPDF Download

Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Recent research



2024/09/18 17:35:08
Price
10.06 EUR
Difference -2.00% (-0.21)

General attributes

ISINES0171996087
SymbolGRF
ExchangeBME Continuous Market
CurrencyEUR
SectorChemical / Pharmaceutical / Health
Security typeStock
Market cap (m)6,378 EUR
BenchmarkIBEX 35

Market data

Bid (Bid size)-
Ask (Ask size)-
Open10.225 EUR
High10.235 EUR
Low10.005 EUR
Close (prev. day)10.265 EUR
VWAP10.084701 EUR
Volume (pcs)1,079,004
Trading volume10,881,432.52
Number of trades1,943
Last size-

Performance and Risk

6m1Y3Y
Perf (%)+34.35%-22.85%-53.90%
Perf (abs.)+2.57-2.98-11.76
Beta---
Volatility48.2979.6958.03
Scale: ABS REL         Instrument

Add Benchmark:



Information about previous performance does not guarantee future performance.
Source: FactSet

Price data

Ø price 5 days | Ø volume 5 days (pcs.)10.14 EUR (1,449,857)
Ø price 30 days | Ø volume 30 days (pcs.)9.41 EUR (1,656,398)
Ø price 100 days | Ø volume 100 days (pcs.)9.27 EUR (2,379,570)
Ø price 250 days | Ø volume 250 days (pcs.)10.18 EUR (2,844,596)
YTD High | date15.63 EUR (2024/01/02)
YTD Low | date6.36 EUR (2024/03/06)
52 Weeks High | date15.92 EUR (2023/12/29)
52 Weeks Low | date6.36 EUR (2024/03/06)

All listings for GRIFOLS SA

Exchange  DateTimePriceTrading volume (mio.)Number of trades
BME Continuous Market2024/09/1817:3510.06 EUR10.881,943
Berlin2024/09/1821:5010.01 EUR0.0019
Duesseldorf2024/09/1819:319.828 EUR0.007
FINRA other OTC Issues2024/09/1119:1410.41 USD0.011
Frankfurt2024/09/1809:0810.155 EUR0.002
Hanover2024/09/1817:2510.06 EUR0.004
London Stock Exchange European Trade Reporting2024/09/1817:3010.0865 EUR0.002
Munich2024/09/1808:1210.16 EUR0.002
Stuttgart2024/09/1808:079.944 EUR0.003
Tradegate2024/09/1822:2610.20 EUR0.0927
Vienna Stock Exchange2024/09/1815:3010.115 EUR0.004

Company Logo

https://gateway.mdgms.com/extern/logo_image.html?ID_LOGO=11140&ID_TYPE_IMAGE_LOGO=2

Contact Details

GRIFOLS SA
- -
Avinguda de la Generalitat, 152-158, Parc de Negocis Can Sant Joan - 08174 Barcelona
Telefon: +34-93-571-02-21
Fax: +34-93-571-02-67
E-mail: -

PDF Downloads

Company report: GRIFOLS SAPDF Download

Company Profile

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Members of Management Board

Nacho AbiaChairman of Managing Board
Raimon Grifols RouraMember of Executive Committee
Thomas GlanzmannMember of Executive Committee
Víctor Grífols DeuMember of Executive Committee

Board of directors

Thomas Heinrich GlanzmannChairman of Supervisory Board
Enriqueta Felip FontMember of Supervisory Board
Albert Coma-CrosMember of Supervisory Board
Anne-Catherine BernerMember of Supervisory Board
James CostosMember of Supervisory Board
Montserrat Muñoz AbellanaMember of Supervisory Board
Susana González RodríguezMember of Supervisory Board
Tomás Dagá GelabertMember of Supervisory Board
Íñigo Sánchez-Asiaín MardonesMember of Supervisory Board





Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer